<
OHBs, Fundamentals

OHB's Fundamentals and Its Share Price Are Telling Two Different Stories

Published on 09/10/2026 at 15:11 | Editorial boerse-global.de

OHB's H1 2026 output rose 11% to €628M and a €1B SES contract was signed, yet the stock slid on a P/E near 60 after a 174% run.

OHB SE Stock Falls 11.6% After €1B SES Deal Despite Strong H1 2026 Results
OHB's Fundamentals and Its Share Price Are Telling Two Different Stories Illustration mit AI erstellt.

Bremen's OHB SE has spent the past several weeks watching its operational performance and its stock market valuation move in opposite directions. The space and technology group delivered a set of first-half 2026 figures that would ordinarily draw applause, yet the equity has continued to bleed value, leaving investors to puzzle over a disconnect that no single news item seems to explain.

A half-year that beat the prior year on every line

Total output for the first six months of 2026 came in at EUR 628 million, an 11 percent improvement over the same period a year earlier. Adjusted EBITDA climbed 31 percent to EUR 60 million, while adjusted EBIT jumped 46 percent to EUR 39 million. Revenue, reported at EUR 627.9 million, matched that 11 percent growth rate, and adjusted EBITDA of EUR 60.4 million confirmed the same 31 percent advance.

Management left its full-year guidance untouched: EUR 1.4 billion in total output and an adjusted EBITDA margin between 10.5 and 11 percent. The order book, meanwhile, hit a record EUR 3.304 billion, complemented by a project pipeline valued at roughly EUR 20 billion. Headcount expanded by about half within a year to approximately 4,100 employees, and the digital segment's order intake swelled 70 percent.

A balance sheet transformed by June's capital raise

The growth narrative rests on firmer financial ground than it did a year ago. A capital increase completed in June pulled net leverage from 1.9x down to minus 1.1x and lifted the equity ratio above 40 percent. Ownership shifted noticeably in the process: the Fuchs family retains 60.3 percent, financial investor KKR holds 19.7 percent through its vehicle Orchid Lux HoldCo, and the remainder sits in free float.

Should investors sell immediately? Or is it worth buying OHB SE?

The €1 billion SES contract — and the sell-the-news reaction

Late in August, OHB signed a contract with European satellite operator SES worth just under EUR 1 billion to develop and build 18 medium-Earth-orbit satellite platforms under the EU's IRIS² communications system. The deal followed the official launch of the IRIS² implementation phase in early August and ranks as the first major order tied to the EU satellite concession. The mission is slated to begin in 2029, with initial services expected by 2030.

The market's response was instructive. The stock initially spiked, then dropped more than 10 percent the following day — a textbook sell-the-news pattern. In the roughly one week since the announcement, the shares have shed about 11.6 percent. A recent addition to the SDAX index, where OHB took Klöckner's slot about a month ago, did nothing to reverse the slide.

Valuation, not operations, is doing the damage

The most plausible explanation for the divergence lies in the multiple investors are willing to pay. After a 174 percent gain over the trailing twelve months, much of the good news had already been priced in. A price-to-earnings ratio near 60 leaves little room for disappointment — even modest setbacks in growth expectations can hit the share price disproportionately. Media reports noted that the rally through May 2026 had run far ahead of the underlying business, and that fantasy is now being unwound piece by piece.

August alone cost the stock roughly 9.3 percent, with valuation concerns already cited as the drag at that time. On Wednesday the shares closed at EUR 181.00, down 2.7 percent on the day, with no identifiable catalyst behind the move. The current price of EUR 179.40 sits about 23 percent below the 50-day moving average of EUR 233.69 — a measure of how thoroughly short-term sentiment has soured.

What emerges is a company whose operational substance is intact but whose market valuation is acutely sensitive to any signal that fails to qualify as an unambiguous positive surprise. Record backlog, a billion-euro contract and confirmed guidance have all failed to provide lasting support. Until that repricing runs its course, even good news out of Bremen is unlikely to calm the volatility.

Ad

OHB SE Stock: New Analysis - 10 September

Fresh OHB SE information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated OHB SE analysis...

Disclaimer...

en | DE0005936124 | OHBS | boerse | 70081688 |